Result of General Meeting

Belluscura PLC

14 June 2023

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF THE MARKET ABUSE REGULATION (EU) NO.596/2014, WHICH FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR"), AS AMENDED.

14 June 2023

Belluscura plc 

("Belluscura", the "Company" or the "Group") 

Result of General Meeting

Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that at the General Meeting held today at 11.00 a.m. all the resolutions proposed were duly passed by the requisite majority:

Resolution (*indicates special resolution)	Votes for	% of shares voted	Votes against	% of shares voted	Total votes
Resolution 1: Authority to allot shares in connection with the Placing, the Subscriptions and Retail Offer	43,674,769	99.92%	36,466	0.08%	43,711,235
Resolution 2*: Disapplication of pre-emption rights in connection with the Placing, Subscriptions and Retail Offer	43,673,774	99.91%	37,461	0.09%	43,711,235

For further information please contact:

Belluscura plc	Tel: [phone]
Adam Reynolds, Chairman  Robert Rauker, Chief Executive Officer  Anthony Dyer, Chief Financial Officer
SPARK Advisory Partners Limited (Nomad)	Tel: [phone]
Neil Baldwin
Dowgate Capital Limited (Broker)	Tel: [phone]
James Serjeant / Russell Cook
MHP (Financial PR & Investor Relations)	Tel: [phone]
Katie Hunt / Matthew Taylor	[e-mail]

 

END